Changes in biochemical markers and prediction of effectiveness of intra-articular hyaluronan in patients with knee osteoarthritis

Osteoarthritis and Cartilage

Volumn 16, Issue 4, 2008, Pages 526-529

  Hasegawa, M ^a   Nakoshi, Y ^a   Tsujii, M ^a   Sudo, A ^a   Masuda, H ^b   Yoshida, T ^a   Uchida, A ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SEIKAGAKU CORPORATION   (Japan)

Author keywords

Biomarker; Hyaluronan; Knee osteoarthritis; Synovial fluid

Indexed keywords

CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; HYALURONIC ACID; KERATAN SULFATE; TENASCIN;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUG EFFICACY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; MALE; PREDICTION; PRIORITY JOURNAL; SYNOVITIS; TREATMENT DURATION; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; SYNOVIAL FLUID; TENASCIN;

EID: 41149098279     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.09.014     Document Type: Article

References (39)

1. Poole A.R., Kojima T., Yasuda T., Mwale F., Kobayashi M., and Laverty S. Composition and structure of articular cartilage: a template for tissue repair. Clin Orthop Relat Res 391 Suppl (2001) S26-S33
2. Poole A.R., Ionescu M., Swan A., and Dieppe P.A. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis. J Clin Invest 94 (1994) 25-33
3. Petersson I.F., Sandqvist L., Svensson B., and Saxne T. Cartilage markers in synovial fluid in symptomatic knee osteoarthritis. Ann Rheum Dis 56 (1997) 64-67
4. Mourao P.A. Distribution of chondroitin 4-sulfate and chondroitin 6-sulfate in human articular and growth cartilage. Arthritis Rheum 31 (1988) 1028-1033
5. Yamada H., Miyauchi S., Hotta H., Morita M., Yoshihara Y., Kikuchi T., et al. Levels of chondroitin sulfate isomers in synovial fluid of patients with hip osteoarthritis. J Orthop Sci 4 (1999) 250-254
6. Thonar E.J., Lenz M.E., Klintworth G.K., Caterson B., Pachman L.M., Glickman P., et al. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum 28 (1985) 1367-1376
7. Garnero P., Rousseau J.C., and Delmas P.D. Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum 43 (2000) 953-968
8. Chiquet-Ehrismann R., Mackie E.J., Pearson C.A., and Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47 (1986) 131-139
9. Jones P.L., and Jones F.S. Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol 19 (2000) 581-596
10. Ghert M.A., Qi W.N., Erickson H.P., Block J.A., and Scully S.P. Tenascin-C expression and distribution in cultured human chondrocytes and chondrosarcoma cells. J Orthop Res 20 (2002) 834-841
11. Hasegawa M., Hirata H., Sudo A., Kato K., Kawase D., Kinoshita N., et al. Tenascin-C concentration in synovial fluid correlates with radiographic progression of knee osteoarthritis. J Rheumatol 31 (2004) 2021-2026
12. Hasegawa M., Nakoshi Y., Muraki M., Sudo A., Kinoshita N., Yoshida T., et al. Expression of large tenascin-C splice variants in synovial fluid of patients with rheumatoid arthritis. J Orthop Res 25 (2007) 563-568
13. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 29 (1986) 1039-1049
14. Kellgren J.H., and Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16 (1957) 494-502
15. Yoshida K., Miyauchi S., Kikuchi H., Tawada A., and Tokuyasu K. Analysis of unsaturated disaccharides from glycosaminoglycuronan by high-performance liquid chromatography. Anal Biochem 177 (1989) 327-332
16. Shinmei M., Miyauchi S., Machida A., and Miyazaki K. Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid. Arthritis Rheum 35 (1992) 1304-1308
17. Yamada H., Miyauchi S., Morita M., Yoshida Y., Yoshihara Y., Kikuchi T., et al. Content and sulfation pattern of keratan sulfate in hip osteoarthritis using high performance liquid chromatography. J Rheumatol 27 (2000) 1721-1724
18. Wang C.T., Lin J., Chang C.J., Lin Y.T., and Hou S.M. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86-A (2004) 538-545
19. Petrella R.J., and Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intra-articular hyaluronic acid for osteoarthritis of the knee. J Rheumatol 33 (2006) 951-956
20. Strand V., Conaghan P.G., Lohmander L.S., Koutsoukos A.D., Hurley F.L., Bird H., et al. An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the knee. Osteoarthritis Cartilage 14 (2006) 859-866
21. Stitik T.P., Blacksin M.F., Stiskal D.M., Kim J.H., Foye P.M., Schoenherr L., et al. Efficacy and safety of hyaluronan treatment in combination therapy with home exercise for knee osteoarthritis pain. Arch Phys Med Rehabil 88 (2007) 135-141
22. Brandt K.D., Smith Jr. G.N., and Simon L.S. Intra-articular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence?. Arthritis Rheum 43 (2000) 1192-1203
23. Noble P.W., Lake F.R., Henson P.M., and Riches D.W. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest 91 (1993) 2368-2377
24. Homandberg G.A., Hui F., Wen C., Kuettner K.E., and Williams J.M. Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: I. In vitro. Osteoarthritis Cartilage 5 (1997) 309-319
25. Aibe K., Ryu J., and Sano S. Effects of hyaluronic acid on cartilage metabolism in free chondrocytes. J Orthop Sci 1 (1996) 268-276
26. Abatangelo G., Botti P., Del Bue M., Gei G., Samson J.C., Cortivo R., et al. Intra-articular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. I. Biochemical results. Clin Orthop Relat Res 241 (1989) 278-285
27. Kikuchi T., Yamada H., and Shimmei M. Effect of high molecular weight hyaluronan on cartilage degeneration in a rabbit model of osteoarthritis. Osteoarthritis Cartilage 4 (1996) 99-110
28. Yoshioka M., Shimizu C., Harwood F.L., Coutts R.D., and Amiel D. The effects of hyaluronan during the development of osteoarthritis. Osteoarthritis Cartilage 5 (1997) 251-260
29. Hulmes D.J., Marsden M.E., Strachan R.K., Harvey R.E., McInnes N., and Gardner D.L. Intra-articular hyaluronate in experimental rabbit osteoarthritis can prevent changes in cartilage proteoglycan content. Osteoarthritis Cartilage 12 (2004) 232-238
30. Goldberg V.M., and Buckwalter J.A. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage 13 (2005) 216-224
31. Asari A., Miyauchi S., Matsuzaka S., Ito T., Kominami E., and Uchiyama Y. Molecular weight-dependent effects of hyaluronate on the arthritic synovium. Arch Histol Cytol 61 (1998) 125-135
32. Smith Jr. G.N., Myers S.L., Brandt K.D., and Mickler E.A. Effect of intra-articular hyaluronan injection in experimental canine osteoarthritis. Arthritis Rheum 41 (1998) 976-985
33. Altman R.D. Structure-/disease-modifying agents for osteoarthritis. Semin Arthritis Rheum 34 Suppl 2 (2005) 3-5
34. Sharif M., Osborne D.J., Meadows K., Woodhouse S.M., Colvin E.M., Shepstone L., et al. The relevance of chondroitin and keratan sulphate markers in normal and arthritic synovial fluid. Br J Rheumatol 35 (1996) 951-957
35. Campion G.V., McCrae F., Schnitzer T.J., Lenz M.E., Dieppe P.A., and Thonar E.J. Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum 34 (1991) 1254-1259
36. Ishiguro N., Ito T., Ito H., Iwata H., Jugessur H., Ionescu M., et al. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis. Arthritis Rheum 42 (1999) 129-136
37. Creamer P., Sharif M., George E., Meadows K., Cushnaghan J., Shinmei M., et al. Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthritis Cartilage 2 (1994) 133-140
38. Kobayashi K., Matsuzaka S., Yoshida Y., Miyauchi S., Wada Y., and Moriya H. The effects of intra-articularly injected sodium hyaluronate on levels of intact aggrecan and nitric oxide in the joint fluid of patients with knee osteoarthritis. Osteoarthritis Cartilage 12 (2004) 536-542
39. Sugimoto H., Yamada H., Terada N., Kanaji A., Kato S., Date H., et al. Intra-articular injection of high molecular weight hyaluronan for osteoarthritis of the knee - prediction of effectiveness with biological markers. J Rheumatol 33 (2006) 2527-2531